KFF July 2, 2024
Juliette Cubanski, Anthony Damico

The Medicare Part D program provides an outpatient prescription drug benefit to more than 50 million older adults and people with long-term disabilities in Medicare who enroll in private plans, including stand-alone prescription drug plans (PDPs) to supplement traditional Medicare and Medicare Advantage prescription drug plans (MA-PDs) that include drug coverage and other Medicare-covered benefits. This brief analyzes Medicare Part D enrollment and costs in 2024 and trends over time, based on data from the Centers for Medicare & Medicaid Services (CMS).

This analysis highlights the continuing growth of Medicare Advantage drug plans as a source of Part D drug coverage, with enrollment overall concentrated in a handful of large plan sponsors. Average premiums for drug coverage are much lower...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer
Podcast: The Scope of Medicare Fraud
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
Harnessing AI to reduce Medicare errors, improve accuracy, and ease physician burnout
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
Pharmacy benefit managers steer Medicare patients to use their own pharmacies

Share This Article